Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
批准号:
10662347
负责人:
Yang Zhou
金额:
$37.13万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-25 至 2024-07-31
关键词:
AffectBindingBiological AssayCalciumCardiacCardiac MyocytesCellsChromatinCicatrixComputer AnalysisDataDermalDeveloped CountriesDevelopmentFamilyFibroblastsFutureGene ActivationGene Expression ProfilingGenerationsGenesGeneticGenetic TranscriptionGenomicsHeartHeart InjuriesHeart failureHistonesHumanImageIn SituIn VitroInjuryIntercellular JunctionsIon ChannelLeft ventricular structureMapsMembraneMolecularMorbidity - disease rateMusMyocardial InfarctionMyocardial IschemiaMyofibrilsNatural regenerationNeonatalOpticsPatientsPerformancePlayProcessProliferatingRegulationReportingResearchResidual stateRoleRouteSarcomeresStructureSystemTechnologyTestingTherapeuticTimeTissuesTransactivationTransmission Electron Microscopycardiac repairclinical applicationclinical translationcofactorepigenomicsgenetic signaturein vivoinducible gene expressioninsightloss of functionmortalitymouse modelmultiple omicsnoveloverexpressionpenis foreskinprogramsprotein expressionsingle-cell RNA sequencingstem cell differentiationtranscription factortranscriptometranscriptomicstreatment strategytumorigenesisvoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
Direct cardiac reprogramming to generated induced cardiomyocytes (iCMs) from fibroblasts has emerged as a
promising therapeutic strategy for the treatment of heart failure, which is still the leading cause of mortality and
morbidity in the developed country. While much is known regarding iCMs generated from mouse cells, the
adaptation of direct cardiac reprogramming to human cells is hurdled with low efficiency and poor quality
because of intrinsic differences between species. We recently reported the single cell transcriptomic analysis
during human cardiac reprogramming and discovered that the insufficient generation of iCMs is associated
with underdeveloped gene programs, such as ion channel and cell junction, suggesting that additional
reprogramming factors regulating function of cardiomyocytes might be required. In this research program, we
hypothesis that a novel reprogramming factor TBX20 plays an essential role to generate cardiomyocyte identity
by establishing gene programs associated with cardiomyocyte function. In support of our hypothesis, our
preliminary data have shown that TBX20 is largely under-expressed in human iCMs. While forced expression
of TBX20 significantly enhanced reprogramming efficiency accompanied with activation of gene programs
associated with cardiomyocyte function. To test the hypothesis, we propose to 1) further determine the impact
of TBX20 on direct human cardiac reprogramming and 2) determine how TBX20 functions as an essential
reprogramming factor during this process. The main objective of this proposal is to identify the critical role of
TBX20 on regeneration of cardiomyocytes during direct cardiac reprogramming. The completion of this
proposal will not only provide mechanistic insight into how cardiomyocyte identity can be regenerated by direct
cardiac reprogramming but also enable us to generate functional-reliable cardiomyocytes directly from human
non-myocytes for potential heart repair.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fbioe.2022.914450
发表时间:
2022
期刊:
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
影响因子:
5.7
作者:
[Nguyen, Thanh, Wei, Yuhua, Nakada, Yuji, Zhou, Yang, Zhang, Jianyi]
通讯作者:
Zhang, Jianyi
DOI:
10.1016/j.xpro.2022.101560
发表时间:
2022-09-16
期刊:
STAR PROTOCOLS
影响因子:
--
作者:
[Lyra-Leite, Davi M., Gutierrez-Gutierrez, Oscar, Wang, Meimei, Zhou, Yang, Cyganek, Lukas, Burridge, Paul W.]
通讯作者:
Burridge, Paul W.
Targeting CHI3L and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
-
批准号:10850273
-
项目类别:
-
资助金额:$4.47万
-
财政年份:2023
-
负责人:Yang Zhou
-
依托单位:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
-
批准号:10554375
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
-
批准号:10355479
-
项目类别:
-
资助金额:$40.43万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
-
批准号:9887633
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
-
批准号:10033650
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
-
批准号:10455734
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
-
批准号:10245150
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2020
-
负责人:Yang Zhou
-
依托单位:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
-
批准号:10437834
-
项目类别:
-
资助金额:$6.47万
-
财政年份:2013
-
负责人:Yang Zhou
-
依托单位:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
-
批准号:10200080
-
项目类别:
-
资助金额:$5.33万
-
财政年份:2013
-
负责人:Yang Zhou
-
依托单位:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
-
批准号:9573405
-
项目类别:
-
资助金额:$25.63万
-
财政年份:--
-
负责人:Yang Zhou
-
依托单位:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
-
批准号:9979904
-
项目类别:
-
资助金额:$23.52万
-
财政年份:--
-
负责人:Yang Zhou
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: